Status:
RECRUITING
Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches
Lead Sponsor:
University of Kansas Medical Center
Collaborating Sponsors:
Ascension Via Christi Hospitals Wichita, Inc.
Conditions:
Subarachnoid; Hemorrhage, Nontraumatic
Headache
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to evaluate intravenous lidocaine efficacy and safety in treating headache following non-traumatic subarachnoid hemorrhage. Through this prospective analysis, t...
Eligibility Criteria
Inclusion
- Patients \> 18 years;
- Have a favorable neurological status defined as Hunt and Hess score ≤ 3 (as it accounts for patient awareness);
- Can communicate numeric pain scores;
- Are diagnosed with non-traumatic subarachnoid hemorrhage
Exclusion
- The patient is diagnosed with traumatic subarachnoid hemorrhage;
- If the patient is \< 18 years of age;
- If numeric pain scores could not be captured for \> 3 days of hospitalization;
- If the patient had a prior aneurysm;
- Chronic pain not associated with non-traumatic subarachnoid hemorrhage diagnosis;
- A disability before the stroke (\> 2 on modified Rankin Scale score);
- A Hunt and Hess score \> 3;
- Contraindications to lidocaine (significant cardiac disease, arrhythmia, seizures, previous allergic reaction to lidocaine
Key Trial Info
Start Date :
January 31 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2028
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06582810
Start Date
January 31 2025
End Date
July 1 2028
Last Update
July 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ascension Via Christi St. Francis
Wichita, Kansas, United States, 67214